These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16963701)

  • 1. Why SMART about second-line treatment when first-line treatment is being ignored?
    Currie GP
    Chest; 2006 Sep; 130(3):929; author reply 929. PubMed ID: 16963701
    [No Abstract]   [Full Text] [Related]  

  • 2. Comments on the Salmeterol Multicenter Asthma Research Trial.
    Seymour SM; Sullivan EJ; Chowdhury BA; Meyer RJ; Davi RC
    Chest; 2006 Sep; 130(3):930-1; author reply 931. PubMed ID: 16963702
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety of long-acting beta-agonists--an urgent need to clear the air.
    Martinez FD
    N Engl J Med; 2005 Dec; 353(25):2637-9. PubMed ID: 16371628
    [No Abstract]   [Full Text] [Related]  

  • 4. Cause of death in the SMART Trial.
    Williams C
    Chest; 2006 Sep; 130(3):929-30; author reply 930. PubMed ID: 16963700
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety of long-acting beta-agonists.
    O'Connor GT
    N Engl J Med; 2006 Mar; 354(11):1206-8; author reply 1206-8. PubMed ID: 16548074
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of long-acting beta-agonists.
    Mintz ML
    N Engl J Med; 2006 Mar; 354(11):1206-8; author reply 1206-8. PubMed ID: 16540628
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta2 déjà vu.
    O'Byrne PM; Adelroth E
    Chest; 2006 Jan; 129(1):3-5. PubMed ID: 16424402
    [No Abstract]   [Full Text] [Related]  

  • 8. Asthma mortality and beta-agonists.
    Skorodin MS
    Chest; 1995 Dec; 108(6):1768. PubMed ID: 7497807
    [No Abstract]   [Full Text] [Related]  

  • 9. Stopping long-acting beta-2 agonists.
    Med Lett Drugs Ther; 2010 Mar; 52(1334):21. PubMed ID: 20336032
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-acting beta-agonists, tachyphylaxis, and corticosteroids.
    Sears MR
    Chest; 1996 Apr; 109(4):862-4. PubMed ID: 8635359
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug safety and salmeterol: the controversy continues.
    Weiss KB
    Ann Intern Med; 2008 Jul; 149(1):56-7. PubMed ID: 18523131
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta 2 agonists and asthma.
    Rees J
    BMJ; 1991 May; 302(6786):1166-7. PubMed ID: 1675134
    [No Abstract]   [Full Text] [Related]  

  • 13. Long acting beta 2 agonists and the risk of life threatening asthma.
    Ernst P
    Thorax; 1998 Jan; 53(1):1-2. PubMed ID: 9577513
    [No Abstract]   [Full Text] [Related]  

  • 14. [More asthma death cases with beta-2-antagonists: with inhaled corticosteroids on the safe side?].
    Wepner U
    MMW Fortschr Med; 2007 Dec; 149(49-50):20. PubMed ID: 18240436
    [No Abstract]   [Full Text] [Related]  

  • 15. Salmeterol xinafoate: an analysis of outcomes and cost-effectiveness using a primary care database.
    Price DB; Cargill K; Wolfe S; Darby H
    Respir Med; 1998 Nov; 92(11):1302-4. PubMed ID: 9926144
    [No Abstract]   [Full Text] [Related]  

  • 16. Exacerbations of asthma in patients on salmeterol.
    Jenkins MM; Hilton CJ; de Kock JC; Palmer JB
    Lancet; 1991 Apr; 337(8746):913-4. PubMed ID: 1672988
    [No Abstract]   [Full Text] [Related]  

  • 17. Salmeterol: a long-acting beta 2-agonist for asthma.
    Nurse Pract; 1994 Jul; 19(7):9-10. PubMed ID: 7936460
    [No Abstract]   [Full Text] [Related]  

  • 18. Misleading data analyses in salmeterol (SMART) study.
    Lurie P; Wolfe SM
    Lancet; 2005 Oct; 366(9493):1261-2; discussion 1262. PubMed ID: 16214589
    [No Abstract]   [Full Text] [Related]  

  • 19. Salmeterol (Serevent) asthma trial halted early.
    Wooltorton E
    CMAJ; 2003 Mar; 168(6):738. PubMed ID: 12642431
    [No Abstract]   [Full Text] [Related]  

  • 20. The US Food and Drug Administration and long-acting beta2-agonists: the importance of striking the right balance between risks and benefits of therapy?
    Lemanske RF; Busse WW
    J Allergy Clin Immunol; 2010 Sep; 126(3):449-52. PubMed ID: 20692690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.